跳至主要内容
临床试验/CTRI/2013/04/003585
CTRI/2013/04/003585招募中Phase 3 4

Levetiracetam in neonatal seizures -a randomised study

Rainbow Childrens Hospital1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2012年6月3日最近更新:

试验速览

阶段
Phase 3 4
状态
招募中
入组人数
100
试验地点
1
主要终点
To study the therapeutic benefit of levetiracetum in neonatal seizures and to compare efficacy with other antiseizure medication.

研究概览

简要总结

to study the therapeutic benefit of levetiracetam in neonatal seizures and to compare efficacy with other anticonvulsant medication.

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Open Label

入排标准

年龄范围
1.00 Day(s) 至 30.00 Day(s)(—)
性别
All

入选标准

  • Babies admitted to NICU with seizures and babies having seizures during NICU stay with •Gestational age ≥ 30 wks Birth weight ≥ 1.5 kg Clinical or electrographic seizures Parental consent obtained.

排除标准

  • Babies with renal serum creatinine > 2.0 Birth at < 30 weeks gestation Parents refuse consent.

结局指标

主要结局

To study the therapeutic benefit of levetiracetum in neonatal seizures and to compare efficacy with other antiseizure medication.

时间窗: 30/06/2013

次要结局

  • use of leviteracetam in various types of neonatal seizures(30/6/2013)

研究者

申办方类型
Private hospital/clinic

研究点 (1)

Loading locations...

相似试验

Levetiracetam for management of seizures in newborn | 临床试验